2020-03-23
N4 Pharma, a pharmaceutical company offering novel drug delivery platforms for vaccines and therapeutics, has signed a 14-month agreement with Nanomerics Ltd., a leading innovator specializing in pharmaceutical nanotechnology. The two partners are to use N4 Pharma’s Nuvec® – a unique non-viral adjuvant delivery platform based on silica nanoparticles – to test the delivery of two drug candidates.
